3.99
price down icon1.24%   -0.05
after-market Dopo l'orario di chiusura: 3.77 -0.22 -5.51%
loading

Titan Pharmaceuticals Inc De Borsa (TTNP) Ultime notizie

pulisher
Aug 01, 2025

Xenon Pharmaceuticals Expands Team: Grants $739K in Stock Options to 6 New Hires - Stock Titan

Aug 01, 2025
pulisher
Jul 31, 2025

SHEN files 8-K, releases Q2 2025 earnings press release | ADIL SEC FilingForm 424B5 - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

Acurx Pharmaceuticals Plans Major 1:20 Reverse SplitKey Details for Nasdaq Compliance - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

Lexicon Pharmaceuticals Meets $1 Minimum Share Price, Secures Critical Nasdaq Listing Status - Stock Titan

Jul 31, 2025
pulisher
Jul 29, 2025

Cumberland Pharmaceuticals Sets Q2 Earnings Date: FDA-Approved Drug Portfolio Update Coming August 5 - Stock Titan

Jul 29, 2025
pulisher
Jul 28, 2025

Supernus-Sage $12B Merger Gets Key Regulatory Green Light as Tender Offer Deadline Nears - Stock Titan

Jul 28, 2025
pulisher
Jul 26, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders - GlobeNewswire Inc.

Jul 26, 2025
pulisher
Jul 25, 2025

Phio Pharmaceuticals Advances Cancer Drug Production with Strategic US Manufacturing Partnership - Stock Titan

Jul 25, 2025
pulisher
Jul 23, 2025

Titan Pharmaceuticals Announces Merger with Black Titan - The Globe and Mail

Jul 23, 2025
pulisher
Jul 21, 2025

Amneal (AMRX) targets $2.55B debt refinancing via loans & notes | AMRX SEC FilingForm 8-K - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Titan Pharmaceuticals Inc. stockFree Smart Trading Workshop - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 15, 2025

Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Major FDA Development: Pierre Fabre Assumes Control of Atara's EBV Cell Therapy Program After BLA Resubmission - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

INKT sets up $50M ATM with B. Riley, adds financing flexibility | INKT SEC FilingForm 8-K - Stock Titan

Jul 15, 2025
pulisher
Jul 14, 2025

ESSA Pharma Shareholders to Receive $1.91 Cash Plus CVR in XenoTherapeutics Acquisition Deal - Stock Titan

Jul 14, 2025
pulisher
Jul 11, 2025

RYTM raises $188.7M via 2.37M-share offering at $85 | RYTM SEC FilingForm 8-K - Stock Titan

Jul 11, 2025
pulisher
Jul 11, 2025

MIST gets FDA review nod; PDUFA set for Dec 13 2025 – covenant aligned | MIST SEC FilingForm 8-K - Stock Titan

Jul 11, 2025
pulisher
Jul 11, 2025

FDA Sets New December 2025 Decision Date for Milestone's PSVT Nasal Spray, Secures $75M Funding - Stock Titan

Jul 11, 2025
pulisher
Jul 10, 2025

Local Bounti (LOCL) insider files Form 144 to sell 3,500 shares - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Rhythm Pharmaceuticals Raises Massive $175M in Upsized Offering for Rare Disease Drug Development - Stock Titan

Jul 10, 2025
pulisher
Jul 09, 2025

GILT lands >$22M Tier-One satellite orders, boosts multi-orbit momentum | EVOK SEC FilingForm 8-K - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

Rare Disease Biotech Rhythm Pharmaceuticals Unveils $150M Stock Offering with Additional $22.5M Option - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

Citius Pharma Dodges Delisting: Stock Maintains $1+ Price for 10 Straight Days, Secures Nasdaq Future - Stock Titan

Jul 08, 2025
pulisher
Jul 07, 2025

Merck & Co.: A Pharma Titan At A Discount (NYSE:MRK) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals Grants 23,075 Stock Options to 10 New Hires with 4-Year Vesting Terms - Stock Titan

Jul 07, 2025
pulisher
Jul 03, 2025

XENE CEO Named Interim CFO After Sherry Aulin Resigns | XENE SEC FilingForm 8-K - Stock Titan

Jul 03, 2025
pulisher
Jul 02, 2025

Cyclacel Announces Major Share Restructuring: 23.7M Shares Consolidating to 1.58M - Stock Titan

Jul 02, 2025
pulisher
Jul 01, 2025

Verrica Secures $18M in Milestones as Phase 3 Wart Treatment Trial Targets Massive Untapped Market - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Elite Pharmaceuticals Crushes Earnings: 81% Profit Jump Reveals Massive Growth from New Drug Launch - Stock Titan

Jun 30, 2025
pulisher
Jun 27, 2025

Titan Pharmaceuticals Raises $600,000 Through Convertible Preferred Stock at $3.40 Conversion Price - Stock Titan

Jun 27, 2025
pulisher
Jun 26, 2025

Reviva Pharma Raises $10M: New Offering Includes Warrants with 5-Year Exercise Window at $0.50 - Stock Titan

Jun 26, 2025
pulisher
Jun 25, 2025

Adial Secures Critical US Manufacturing Deal With Thermo Fisher for Alcohol Use Disorder Drug - Stock Titan

Jun 25, 2025
pulisher
Jun 24, 2025

InMed's Alzheimer's Drug Shows Promise in Breakthrough Preclinical Study | INM SEC FilingForm 8-K - Stock Titan

Jun 24, 2025
pulisher
Jun 23, 2025

Elite Pharmaceuticals to Reveal Full Year 2025 Performance: Key Earnings Call Details Inside - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

Inozyme Pharma Halts Annual Meeting as BioMarin Acquisition Nears Completion - Stock Titan

Jun 20, 2025
pulisher
Jun 18, 2025

AGIO files Form S-8 to add shares to 2023 Stock Incentive Plan - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

Lobe Sciences Secures $26M for Novel Chronic Cluster Headache Drug Development | LOBEF Stock News - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals Secures $7M Funding: Next-Generation Cancer Drug Trial Gets Green Light - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

NRx Pharmaceuticals Taps Top Biotech IR Firm ahead of Critical FDA Filings and Clinic Acquisitions - Stock Titan

Jun 16, 2025
pulisher
Jun 11, 2025

Breakthrough Systemic Sclerosis Treatment Shows Promise in Top EULAR Study | CRVS Stock News - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

Biotech to Environmental Services: Windtree's $12M Revenue Play in $85B Waste Management Market - Stock Titan

Jun 10, 2025
pulisher
Jun 04, 2025

Titan Medical (NASDAQ:TMDIF) Stock Price Down 2.4% – Here’s Why - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Apellis Reveals New Insights at Goldman Sachs Healthcare Conference: How to Watch Live - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

Merger Alert: Titan Pharmaceuticals Takes Major Step Toward TalenTec Combination with Critical SEC Filing - Stock Titan

Jun 03, 2025
pulisher
May 29, 2025

Biotech to AI: Bionoid Pharma Makes Bold Pivot with New Identity as AI Maverick Intel - Stock Titan

May 29, 2025
pulisher
May 28, 2025

ORIC Lands Massive $125M Investment Led by SR One, Extending Runway Through Critical Phase 3 Cancer Trial - Stock Titan

May 28, 2025
pulisher
May 27, 2025

Clinical Data: Vanda Unveils Key Bioequivalence Study Results for Next-Gen Psychiatric Drug at Major Conference - Stock Titan

May 27, 2025
pulisher
May 23, 2025

Crinetics Management Team Set for Key Presentation at Major Jefferies Healthcare Conference - Stock Titan

May 23, 2025
pulisher
May 22, 2025

Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Petros Pharmaceuticals Faces NASDAQ Delisting Despite $10M Cash Position, Plans Appeal - Stock Titan

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Secures Future on Nasdaq: Clears Both Bid Price and Equity Hurdles - Stock Titan

May 21, 2025
pulisher
May 20, 2025

Petros Partners with Innolitics: $10M Cash Powers Game-Changing OTC Drug Development Platform - Stock Titan

May 20, 2025
pulisher
May 19, 2025

CASI Pharmaceuticals Schedules Major Business and Clinical Pipeline Review: What Investors Should Watch - Stock Titan

May 19, 2025
pulisher
May 16, 2025

Conduit Pharma Sets 15:1 Reverse Split: Shares Drop to 755,900 Starting May 20 - Stock Titan

May 16, 2025
pulisher
May 16, 2025

Biotech Company Makes Bold Leap into AI: Bionoid Pharma Rebrands as AI Maverick Intel - Stock Titan

May 16, 2025
pulisher
May 15, 2025

HOPE Therapeutics Lands $7.8M Deal to Build National Mental Health Network with Ketamine Treatment Centers - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Regeneron Secures Massive $407M Victory: Jury Finds Amgen Guilty of Illegal PCSK9 Drug Bundling Scheme - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Citius Pharmaceuticals Reports Critical Cash Position, Advances FDA-Approved LYMPHIR Launch Strategy - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update - Stock Titan

May 13, 2025
pulisher
May 12, 2025

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025 - Stock Titan

May 12, 2025
pulisher
May 12, 2025

/C O R R E C T I O N -- Hoth Therapeutics, Inc./ - Stock Titan

May 12, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - Stock Titan

May 09, 2025
pulisher
May 08, 2025

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results - Stock Titan

May 08, 2025
pulisher
May 07, 2025

CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT | CYCC Stock News - Stock Titan

May 07, 2025
pulisher
May 06, 2025

NRXP Reveals Major Mental Health Expansion Plans at Exclusive Mar-A-Lago Investor Event - Stock Titan

May 06, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Capitalizzazione:     |  Volume (24 ore):